Adriana Ilardi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Adriana Ilardi has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Adele Valentini
Unità Operativa Radiologia Diagnostica per Immagini 1, Fondazione IRCCS Policlinico San Matteo, Viale Golgi, 19, 27100 Pavia, PV, Italy
1 shared publication - Antonella Priore1 shared publication
- Antonio Basile
Radiology Unit 1, Department of Medical Surgical Sciences and Advanced Technologies “GF Ingrassia”, University Hospital Policlinico “G. Rodolico-San Marco”, University of Catania, 95123 Catania, Italy
1 shared publication - Bruno Curia1 shared publication
- Carlotta Scavone
Department of Medical Surgical Sciences and Advanced Technologies “GF Ingrassia”, University Hospital Policlinico “G. Rodolico-San Marco”, Catania, Italy
1 shared publication - Carlotta Zilioli
PAR UNIVERSITY HOSPITAL , Parma , Italy
1 shared publication
Latest Publications
- Open Access
- 6 February 2024
- Published by Springer Nature in La radiologia medica
- Vol. 129 (3) , 411-419
Study rationale and design of the PEOPLHE trial
Purpose: Lung cancer screening (LCS) by low-dose computed tomography (LDCT) demonstrated a 20–40% reduction in lung cancer mortality. National stakeholders and international scientific societies are increasingly endorsing LCS programs, but translating their benefits into practice is rather challenging. The “Model for Optimized Implementation of Early Lung Cancer Detection: Prospective Evaluation Of Preventive Lung HEalth” (PEOPLHE) is an Italian multicentric LCS program aiming at testing LCS feasibility and implementation within the national healthcare system. PEOPLHE is intended to assess (i) strategies to optimize LCS workflow, (ii) radiological quality assurance, and (iii) the need for dedicated resources, including smoking cessation facilities. Methods: PEOPLHE aims to recruit 1.500 high-risk individuals across three tertiary general hospitals in three different Italian regions that provide comprehensive services to large populations to explore geographic, demographic, and socioeconomic diversities. Screening by LDCT will target current or former (quitting < 10 years) smokers (> 15 cigarettes/day for > 25 years, or > 10 cigarettes/day for > 30 years) aged 50–75 years. Lung nodules will be volumetric measured and classified by a modified PEOPLHE Lung-RADS 1.1 system. Current smokers will be offered smoking cessation support. Conclusion: The PEOPLHE program will provide information on strategies for screening enrollment and smoking cessation interventions; administrative, organizational, and radiological needs for performing a state-of-the-art LCS; collateral and incidental findings (both pulmonary and extrapulmonary), contributing to the LCS implementation within national healthcare systems.
- 6 February 2024
- Published by Springer Nature in La radiologia medica
- Vol. 129 (3) , 411-419
Open AccessStudy rationale and design of the PEOPLHE trial
Purpose: Lung cancer screening (LCS) by low-dose computed tomography (LDCT) demonstrated a 20–40% reduction in lung cancer mortality. National stakeholders and international scientific societies are increasingly endorsing LCS programs, but translating their benefits into practice is rather challenging. The “Model for Optimized Implementation of Early Lung Cancer Detection: Prospective Evaluation Of Preventive Lung HEalth” (PEOPLHE) is an Italian multicentric LCS program aiming at testing LCS feasibility and implementation within the national healthcare system. PEOPLHE is intended to assess (i) strategies to optimize LCS workflow, (ii) radiological quality assurance, and (iii) the need for dedicated resources, including smoking cessation facilities. Methods: PEOPLHE aims to recruit 1.500 high-risk individuals across three tertiary general hospitals in three different Italian regions that provide comprehensive services to large populations to explore geographic, demographic, and socioeconomic diversities. Screening by LDCT will target current or former (quitting < 10 years) smokers (> 15 cigarettes/day for > 25 years, or > 10 cigarettes/day for > 30 years) aged 50–75 years. Lung nodules will be volumetric measured and classified by a modified PEOPLHE Lung-RADS 1.1 system. Current smokers will be offered smoking cessation support. Conclusion: The PEOPLHE program will provide information on strategies for screening enrollment and smoking cessation interventions; administrative, organizational, and radiological needs for performing a state-of-the-art LCS; collateral and incidental findings (both pulmonary and extrapulmonary), contributing to the LCS implementation within national healthcare systems.
- Open Access
- 9 October 2023
- Published by Elsevier in Radiology Case Reports
- Vol. 18 (12) , 4439-4442
Endovascular treatment of pulmonary artery aneurysm: Single case experience
- 9 October 2023
- Published by Elsevier in Radiology Case Reports
- Vol. 18 (12) , 4439-4442
Open AccessEndovascular treatment of pulmonary artery aneurysm: Single case experience